Pure Global
NCT04531852

Community-based Complex Intervention to Prevent Loss of Physical Function and Disability in Home-dwelling Older Adults

Tailored Exercise and Behavioural Intervention to Modify Risk Factors Associated With Loss of Physical Function and Disability in Older Adults: Results From the Community-based Welfare Innovation in Primary Prevention Project (WIPP)
University of Southern Denmark·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Disability Physical
Drug/Device/Intervention
CALSTI - Complex Active Lifestyle Intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University of Southern Denmark
Location
Esbjerg,Odense,Slagelse, Denmark
Timeline & enrollment
Phase
N/A
Start date
Jun 22, 2017
End date
Dec 22, 2019
Enrollment
360 participants
Primary outcome

Change in physical function

Summary

The aim of this study is to compare the effect of 12 weeks group-based exercise program
 enhanced with 24 weeks health empowerment program (HEP) to an extended usual care condition
 (the HEP program alone) on physical function, disability, health-related quality of life
 (HQoL) in home-dwelling older adults at risk for disability. Interventions were implemented
 into existing health care pathways and added to routine preventive programs using a two-armed
 randomized intervention design with multiple sites.

ICD-10 classifications
Other physical therapyLimitation of activities due to disabilityDependence on wheelchairPostprocedural musculoskeletal disorders, not elsewhere classifiedFamily history of other disabilities and chronic diseases leading to disablement, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04531852
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04531852 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Southern Denmark and is currently Completed. The study focuses on Disability Physical. Target enrollment is 360 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.